Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/28/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Vor Biopharma Inc. (VOR) Misses Q1 EPS by 6c
May 9, 2024 4:27 PM EDTVor Biopharma Inc. (NASDAQ: VOR) reported Q1 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.
... More